1. Home
  2. ABVX vs CPAC Comparison

ABVX vs CPAC Comparison

Compare ABVX & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • CPAC
  • Stock Information
  • Founded
  • ABVX 2013
  • CPAC 1949
  • Country
  • ABVX France
  • CPAC Peru
  • Employees
  • ABVX N/A
  • CPAC N/A
  • Industry
  • ABVX
  • CPAC Building Materials
  • Sector
  • ABVX
  • CPAC Industrials
  • Exchange
  • ABVX Nasdaq
  • CPAC Nasdaq
  • Market Cap
  • ABVX 451.5M
  • CPAC 436.7M
  • IPO Year
  • ABVX N/A
  • CPAC 2012
  • Fundamental
  • Price
  • ABVX $6.92
  • CPAC $5.50
  • Analyst Decision
  • ABVX Strong Buy
  • CPAC Sell
  • Analyst Count
  • ABVX 5
  • CPAC 1
  • Target Price
  • ABVX $33.80
  • CPAC $6.00
  • AVG Volume (30 Days)
  • ABVX 100.3K
  • CPAC 7.6K
  • Earning Date
  • ABVX 03-24-2025
  • CPAC 04-28-2025
  • Dividend Yield
  • ABVX N/A
  • CPAC 9.05%
  • EPS Growth
  • ABVX N/A
  • CPAC 15.59
  • EPS
  • ABVX N/A
  • CPAC 0.13
  • Revenue
  • ABVX $11,172,999.00
  • CPAC $545,786,617.00
  • Revenue This Year
  • ABVX $284.20
  • CPAC N/A
  • Revenue Next Year
  • ABVX N/A
  • CPAC N/A
  • P/E Ratio
  • ABVX N/A
  • CPAC $8.70
  • Revenue Growth
  • ABVX 135.94
  • CPAC 2.78
  • 52 Week Low
  • ABVX $4.77
  • CPAC $5.10
  • 52 Week High
  • ABVX $14.75
  • CPAC $6.65
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 55.03
  • CPAC 48.74
  • Support Level
  • ABVX $6.54
  • CPAC $5.20
  • Resistance Level
  • ABVX $7.83
  • CPAC $5.59
  • Average True Range (ATR)
  • ABVX 0.52
  • CPAC 0.12
  • MACD
  • ABVX 0.01
  • CPAC 0.01
  • Stochastic Oscillator
  • ABVX 43.89
  • CPAC 63.62

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: